Bioseparation Forum

Virtual BioSeparation Forum

Gain insights into chromatography, new therapies, and antibody manufacturing & characterization

Based on the track record of the BioSeparation Forum events we created a virtual event packed with inspiring presentations, scientific updates and opportunities to connect with your peers. On October1, the virtual BioSeparation Forum will present an overview on the use of bio-chromatography for manufacturing and analysis of specific target molecules.

Register here

1st virtual BioSeparation Forum, October 1, 2020

Manufacturing - New Therapies & Antibodies

Morning session: 9:00-12:30

Development of production processes for vaccines and viral vectors
(Michael W. Wolff, University Giessen)

Tackling the capacity bottleneck in downstream processing of viral vectors
(Kai Touw, Batavia Biosciences)

Process intensification by parallel, flow through chromatography and counter current chromatography
(Alois Jungbauer, BOKU Vienna)

Reduce downstream processing cost for mAbs by using a 2-step platform
(Romain Dabre, Tosoh Bioscience)

Approaches enabling antibody manufacturing at pandemic speed
(Anja Trapp, Rentschler Biopharma)

Analytics - Speed & Accuracy

Afternoon session: 14:00-16:30

SEC-MS; considerations when adding this extra dimension to your protein characterization workflow
(Rob Haselberg, VU Amsterdam)

A new chromatographic approach to quickly asses glycan profiles in process development
(Marcel Nowak & Stephan Schultz, UGA Biopharma)

The generic SEC method in a global company
(Alexander Knaupp, Roche Diagnostics GmbH)

LenS3 – MALS Technology for next generation biopharmaceuticals
(Patrick Endress, Tosoh Bioscience)

Register here

Download abstracts

To be in the loop of the latest news on the BioSeparation Forum, opt-in here » and select the area of interest "Seminars/Events".

 

Virtual BioSeparation Forum